Patients with uncontrolled hypertension, active infection, or certain cardiac conditions should consult providers before use
The 2024 Yang paper in Journal for ImmunoTherapy of Cancer documented NNMT in cancer-associated fibroblasts driving tumour progression (PMID 39067875)
This is why the consultation stage is an important part of the process, as it determines the best way forward
Realworld timelines vary depending on the specific peptide, dose, adherence, and how well nutrition, movement, and sleep are addressed alongside the medication
Some theorize that supplementing T4 could support joint healing and reduce inflammation
Additionally, patients may experience secondary systemic symptoms such as confusion, tendon reflex hyperactivity, reversible dementia, mood swings, psychotic symptoms, and hypertension,